Send feedback

FTCD p.Ala455Val

c.1364C>T · rs61735840 · VCV666112

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.2074 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.164%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
2
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.2074likely benign
REVEL0.317indeterminate
SaProtLLR -9.00tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 9.2GERP 1.5, phastCons 1
Regional constrainto/e 1.12unconstrained · MANE · 19 kb · p 0.00063 · regional, not allelic
Overall
CADD21.4PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.164% African / African-American · 123/74,834 alleles
Filtering AF 0.141% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.132%
Overall 0.0209% 332/1,589,234 alleles · rare exomes 240/1,436,988 · genomes 92/152,246 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.188% 532
African / African-Americangrpmax 0.164% 608
South Asian 0.0246% 4,058
Remaining individualsnot grpmax-eligible 0.0194% 5,154
Middle Eastern 0.0177% 5,660
East Asian 0.0135% 7,411
Admixed American 0.0103% 9,669
European (non-Finnish) 0.00911% 10,980

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
FTCD
Protein
p.Ala455Val
Coding
c.1364C>T
MANE Select
NM_206965
dbSNP
rs61735840
Type
single nucleotide variant
Location
chr21:46138587 (GRCh38)
Gene constraint
LOEUF 1.61 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 95.30
Residue 455
the 'cyclodeaminase/cyclohydrolase' region
Full FTCD gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ftcd-p-ala455val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown